IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 161 filers reported holding IMPAX LABORATORIES INC in Q3 2014. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $30,069,000 | -0.6% | 1,545,951 | -14.9% | 0.03% | +3.7% |
| Q4 2017 | $30,244,000 | +1440.7% | 1,816,486 | +1778.0% | 0.03% | +1250.0% |
| Q3 2017 | $1,963,000 | +113.1% | 96,722 | +68.9% | 0.00% | +100.0% |
| Q2 2017 | $921,000 | -12.1% | 57,266 | -30.9% | 0.00% | 0.0% |
| Q1 2017 | $1,048,000 | -80.0% | 82,834 | -79.1% | 0.00% | -80.0% |
| Q4 2016 | $5,240,000 | +174.9% | 395,439 | +391.7% | 0.01% | +150.0% |
| Q3 2016 | $1,906,000 | -38.9% | 80,417 | -25.7% | 0.00% | -33.3% |
| Q2 2016 | $3,119,000 | +85.8% | 108,237 | +106.5% | 0.00% | +50.0% |
| Q1 2016 | $1,679,000 | -67.9% | 52,426 | -57.1% | 0.00% | -66.7% |
| Q4 2015 | $5,227,000 | +26.0% | 122,249 | +3.8% | 0.01% | +20.0% |
| Q3 2015 | $4,147,000 | -32.9% | 117,789 | -12.5% | 0.01% | -16.7% |
| Q2 2015 | $6,182,000 | +118.4% | 134,608 | +123.0% | 0.01% | +100.0% |
| Q1 2015 | $2,830,000 | +71.6% | 60,363 | +15.9% | 0.00% | +200.0% |
| Q4 2014 | $1,649,000 | -17.1% | 52,079 | -37.9% | 0.00% | -50.0% |
| Q3 2014 | $1,989,000 | -32.6% | 83,901 | -14.7% | 0.00% | 0.0% |
| Q2 2014 | $2,950,000 | -2.5% | 98,340 | -14.1% | 0.00% | -33.3% |
| Q1 2014 | $3,026,000 | +3.6% | 114,546 | -1.4% | 0.00% | 0.0% |
| Q4 2013 | $2,921,000 | +30.2% | 116,215 | +6.0% | 0.00% | +50.0% |
| Q3 2013 | $2,244,000 | +70.9% | 109,636 | +66.5% | 0.00% | +100.0% |
| Q2 2013 | $1,313,000 | -77.4% | 65,859 | -82.5% | 0.00% | -83.3% |
| Q1 2013 | $5,799,000 | – | 375,530 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 423,161 | $13,406,000 | 7.47% |
| Aravt Global | 2,300,000 | $72,864,000 | 5.43% |
| Slate Path Capital LP | 2,330,000 | $73,814,000 | 5.16% |
| Orbimed Advisors | 6,678,000 | $211,559,000 | 2.02% |
| Iguana Healthcare Management, LLC | 100,000 | $3,168,000 | 1.53% |
| Iguana Healthcare Management, LLC | 100,000 | $3,168,000 | 1.53% |
| Penn Capital Management Company, LLC | 709,045 | $22,463,000 | 0.94% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 250,000 | $7,920,000 | 0.79% |
| NEW AMSTERDAM PARTNERS LLC/NY | 276,169 | $8,749,000 | 0.76% |
| Matarin Capital Management, LLC | 52,932 | $1,676,886,000 | 0.74% |